Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies
Clinical trial NCT02358538 · COMPLETED
Trial details
- NCT number
- NCT02358538
- Sponsor
- Marinus Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-06
- Primary completion
- 2018-01-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.